Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 32

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 32
---
 to selling securities which are not “penny stocks.” Rule 15a-9 restricts the solicitation of sales of “penny stocks” by broker-dealers unless the broker first (i) obtains from the purchaser information concerning his financial situation, investment experience and investment objectives, (ii) reasonably determines that the purchaser has sufficient knowledge and experience in financial matters that the person is capable of evaluating the risks of investing in “penny stocks”, and (iii) delivers and receives back from the purchaser a manually signed written statement acknowledging the purchaser’s investment experience and financial sophistication.

Rules 15g-2 through 15g-6 promulgated under the Exchange Act require broker-dealers who engage in transactions in “penny stocks” first to provide their customers with a series of disclosures and documents, including (i) a standardized risk disclosure document identifying the risks inherent in investing in “penny stocks”, (ii) all compensation received by the broker-dealer in connection with the transaction, (iii) current quotation prices and other relevant market data, and (iv) monthly account statements reflecting the fair market value of the securities.

There can be no assurance that any broker-dealer which initiates quotations for the Common Stock will continue to do so, and the loss of any such broker-dealer likely would have a material adverse effect on the market price of our Common Stock.

The market price of our Common Stock may fluctuate significantly in the future.

The market price of our Common Stock could be subject to significant fluctuations in response to the factors described in this section and other factors, many of which are beyond our control. Among the factors that could affect our stock price are:

| ● | competitive pricing pressures; |

| ● | our ability to market our                      
 services on a cost-effective and timely basis; |

| ● | our inability to obtain               
 working capital financing, if needed; |

| ● | changing conditions in 
 the market;            |

| ● | changes in market valuations 
 of similar companies;        |

| ● | stock market price and         
 volume fluctuations generally; |

| ● | regulatory developments; |

| ● | fluctuations in our quarterly 
 or annual operating results;  |

| ● | the                                                                                                                                     
 passage of legislation or other regulatory developments affecting us or our industry changes in expectations as to our future financial 
 performance, including financial estimates by securities analysts and investors, or differences between our actual results and those    
 expected by investors and securities analyst                                                                                            |

| ● | additions or departures 
 of key personnel; and   |